Quadrise Fuels International plc (LON:QFI) Chief Executive Officer Jason Milescaught up with DirectorsTalk for an exclusive interview to discuss the test results for bioMSAR™ on a medium 4-stroke engine, decarbonisation in..
Surface Transforms plc (LON:SCE) are the topic of conversation when Robin Byde joins DirectorsTalk. Robin talks us through the company´s latest update on a contract award, explains the revised manufacturing..
Ulisse BioMed (UBM) has developed three technology platforms that offer great potential, having wide applications in molecular diagnostics and immunoassay. Its most developed product – a polymerase chain reaction (PCR)..
DS Smith Plc (LON:SMDS) has issued a trading update in respect of the period since 1 May 2021. Miles Roberts, DS Smith Group Chief Executive, said: “I am very pleased..
Flowtech Fluidpower plc (LON:FLO), a leading specialist supplier of technical fluid power components and services has announced its 2021 half-year report for the six months ended 30 June 2021. “We are..
Boku Inc. (LON:BOKU), a leading global mobile payment and mobile identity company, is pleased to announce the following unaudited interim results for the six months ended 30 June 2021. Highlights..
Strix Group plc (LON:KETL), the global leader in the design, manufacture and supply of kettle safety controls and other complementary water temperature management components, has announced that the Company’s management..
Poolbeg Pharma plc (LON:POLB), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has provided an update on the strengthening of its intellectual property (IP) position..
Time Finance plc (LON:TIME), the AIM listed independent specialist finance provider, has confirmed, as previously announced on 6 May 2021, that it plans to announce audited annual results for the..
Ilika plc (LON:IKA), a pioneer in solid-state battery technology, has today provided an update on senior appointments and a planned change of Director. To further support the development and commercialisation..
Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology pharmaceutical company specialising in allergy vaccines, has today announced that it will host a webinar entitled ‘VLP Peanut; a next generation..
Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, has noted the..
